GM0N.F - Globus Medical, Inc.

Frankfurt - Frankfurt Delayed Price. Currency in EUR
44.49
-0.17 (-0.38%)
As of 8:04AM CEST. Market open.
Stock chart is not supported by your current browser
Previous Close44.66
Open44.49
Bid45.07 x 10000
Ask45.19 x 10000
Day's Range44.49 - 44.49
52 Week Range23.15 - 44.66
Volume60
Avg. Volume8
Market Cap4.376B
Beta1.07
PE Ratio (TTM)40.45
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • TheStreet.com5 days ago

    3 Fascinating Companies Using AI to Forge New Advances in Healthcare

    When you think of artificial intelligence (AI), you might not immediately think of the healthcare sector. Here we take a closer look at three intriguing stocks using AI to forge new advances in treating and tackling disease. To pinpoint these three stocks, we used TipRanks' data to scan for 'Strong Buy' stocks in the healthcare sector.

  • Globus Medical Inc. Boosts 2018 Outlook After a Strong First Quarter
    Motley Fool20 days ago

    Globus Medical Inc. Boosts 2018 Outlook After a Strong First Quarter

    The new ExcelsiusGPS robotics and navigation system generates big sales growth for the medical-device company in the first quarter.

  • Associated Press20 days ago

    Globus Medical: 1Q Earnings Snapshot

    The Audubon, Pennsylvania-based company said it had net income of 39 cents per share. Earnings, adjusted for one-time gains and costs, were 41 cents per share. The results topped Wall Street expectations. ...

  • Breakout Watch: This Medical Stock Is Outperforming 99% Of All Stocks
    Investor's Business Daily26 days ago

    Breakout Watch: This Medical Stock Is Outperforming 99% Of All Stocks

    Along with Abiomed and Inogen, spinal implant manufacturer Globus Medical is among five top medical stocks with a 99 Composite Rating.

  • Benzingalast month

    BTIG Sees Limited Upside For Globus Medical, Downgrades To Neutral

    Globus Medical Inc (NYSE: GMED ) is up 64 percent year-over-year , but it may be exhausting its potential . The Rating BTIG analyst Ryan Zimmerman downgraded Globus Medical to Neutral. The Thesis Globus ...

  • See what the IHS Markit Score report has to say about Globus Medical Inc.
    Markitlast month

    See what the IHS Markit Score report has to say about Globus Medical Inc.

    Short interest is low for GMED with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. The net inflows of $130 million over the last one-month into ETFs that hold GMED are among the lowest of the last year and appear to be slowing.

  • American City Business Journals3 months ago

    Montco medical device maker plots big push into orthopedic trauma market

    Globus Medical Inc. is making a big push in the orthopedic trauma market. The Audobon, Pa., manufacturer of implants and other devices used in spinal surgery, is displaying its growing portfolio of trauma products at this week's American Association of Orthopaedic Surgeons’ annual meeting in New Orleans. “We feel we can capitalize on our strengths of innovation and speed to market to bring game changing technology in the trauma market,” said Barclay Davis, vice president for orthopedic trauma at Globus.

  • Globus Medical Inc. 4th Quarter: The Rise of the Robot
    Motley Fool3 months ago

    Globus Medical Inc. 4th Quarter: The Rise of the Robot

    The musculoskeletal-implant maker gets a boost from the launch of its Excelsius GPS robotic surgical system.

  • Associated Press3 months ago

    Globus Medical tops Street 4Q forecasts

    On a per-share basis, the Audubon, Pennsylvania-based company said it had net income of 25 cents. Earnings, adjusted for pretax expenses and non-recurring costs, came to 38 cents per share. The results ...

  • Benzinga3 months ago

    Globus Medical Q4 Earnings Preview

    On Wednesday, Globus Medical (NYSE: GMED ) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release. Earnings and Revenue Analysts predict ...

  • Why Globus Medical Inc (NYSE:GMED) Could Be A Buy
    Simply Wall St.3 months ago

    Why Globus Medical Inc (NYSE:GMED) Could Be A Buy

    Globus Medical Inc (NYSE:GMED), a medical equipment company based in United States, received a lot of attention from a substantial price increase on the NYSE over the last few months.Read More...

  • Did Globus Medical Inc (NYSE:GMED) Create Value For Investors Over The Past Year?
    Simply Wall St.3 months ago

    Did Globus Medical Inc (NYSE:GMED) Create Value For Investors Over The Past Year?

    Globus Medical Inc’s (NYSE:GMED) most recent return on equity was a substandard 11.47% relative to its industry performance of 11.49% over the past year. GMED’s results could indicate a relativelyRead More...

  • See what the IHS Markit Score report has to say about Globus Medical Inc.
    Markit3 months ago

    See what the IHS Markit Score report has to say about Globus Medical Inc.

    Short interest is low for GMED with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. The net inflows of $306 million over the last one-month into ETFs that hold GMED are among the lowest of the last year and appear to be slowing.

  • Benzinga5 months ago

    Morgan Stanley Upgrades Globus Medical, Expects 17% Upside

    Globus Medical Inc (NASDAQ: GMED ), a medical device company that's  among the major players in spine robotic surgery technologies, saw its stock gain more than 70 percent in 2017, and one analyst projects ...

  • Motley Fool5 months ago

    Why Globus Medical Should Be on Your Watch List

    GMED has revamped some of their biggest issues, and could be on track for some significant long-term growth.

  • See what the IHS Markit Score report has to say about Globus Medical Inc.
    Markit5 months ago

    See what the IHS Markit Score report has to say about Globus Medical Inc.

    Short interest is low for GMED with fewer than 5% of shares on loan. Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on December 11.

  • See what the IHS Markit Score report has to say about Globus Medical Inc.
    Markit6 months ago

    See what the IHS Markit Score report has to say about Globus Medical Inc.

    Short interest is moderate for GMED with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. The net inflows of $3.46 billion over the last one-month into ETFs that hold GMED are not among the highest of the last year and have been slowing.

  • Mazor Robotics Might Need to Worry About This Potential Rival the Most (Hint: It's Not Intuitive Surgical)
    Motley Fool6 months ago

    Mazor Robotics Might Need to Worry About This Potential Rival the Most (Hint: It's Not Intuitive Surgical)

    A new spine surgery robot has arrived on the scene to challenge Mazor's current dominance.

  • See what the IHS Markit Score report has to say about Globus Medical Inc.
    Markit6 months ago

    See what the IHS Markit Score report has to say about Globus Medical Inc.

    Short interest is moderate for GMED with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, ETFs holding GMED are favorable, with net inflows of $4.14 billion.

  • See what the IHS Markit Score report has to say about Globus Medical Inc.
    Markit6 months ago

    See what the IHS Markit Score report has to say about Globus Medical Inc.

    Short interest is moderate for GMED with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. The net inflows of $3.36 billion over the last one-month into ETFs that hold GMED are not among the highest of the last year and have been slowing.

  • See what the IHS Markit Score report has to say about Globus Medical Inc.
    Markit6 months ago

    See what the IHS Markit Score report has to say about Globus Medical Inc.

    Short interest is moderate for GMED with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, ETFs holding GMED are favorable, with net inflows of $3.78 billion.

  • Stocks Showing Market Leadership: Globus Medical Earns 91 RS Rating
    Investor's Business Daily6 months ago

    Stocks Showing Market Leadership: Globus Medical Earns 91 RS Rating

    Globus Medical shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.

  • Globus Medical (GMED) Looks Good: Stock Adds 7.5% in Session
    Zacks6 months ago

    Globus Medical (GMED) Looks Good: Stock Adds 7.5% in Session

    Globus Medical (GMED) saw its shares rise nearly 8% on the day after the company reported year-over-year growth in third-quarter earnings and revenues.

  • See what the IHS Markit Score report has to say about Globus Medical Inc.
    Markit6 months ago

    See what the IHS Markit Score report has to say about Globus Medical Inc.

    Short interest is moderate for GMED with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. The net inflows of $3.75 billion over the last one-month into ETFs that hold GMED are not among the highest of the last year and have been slowing.

  • Globus Medical Reaches 80-Plus Relative Strength Rating Benchmark
    Investor's Business Daily6 months ago

    Globus Medical Reaches 80-Plus Relative Strength Rating Benchmark

    Globus Medical sees its Relative Strength Rating move into the 80-plus level.